Clinical Trial Update: Zhibitai Capsules for the Treatment of Primary Hyperlipidemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Zhibitai Capsules to treat primary hyperlipidemia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• Zhibitai Capsules

Snippet

Sponsor: Chengdu Diao Jiuhong Pharmaceutical Factory | Conditions: Primary Hyperlipidemia | Phase 2 | Status: RECRUITING